Item 2.02.Results of Operations and Financial Condition.

On March 11, 2020, Entasis Therapeutics Holdings Inc. (the "Company") issued a press release announcing its financial results for the year ended December 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8­K and is incorporated herein by reference.

The information provided in this Form 8­K, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01.Financial Statements and Exhibits.



(d) Exhibits.


        Exhibit
        No.                             Description

        99.1         Press release of the Company, dated March 11, 2020






                                       2

© Edgar Online, source Glimpses